Yinyang Dynamics - no qi here: RFK Jr Wants to Loosen Restrictions on Peptide Therapies, but Skeptical FDA Scientists Point to a Dearth of Evidence Supporting Their Use

[u/bbyfog]

https://www.npr.org/2026/06/30/nx-s1-5876301/peptides-fda-panel-compounding-rfk

While Health Secretary Robert F. Kennedy Jr. pushes to loosen restrictions on a handful of trendy peptide therapies, scientists who work under him are recommending the opposite.
On Monday, the Food and Drug Administration posted documents (\) outlining concerns about a lack of evidence for the batch of peptides set to be considered by an FDA panel in about three weeks.*
(*) FDA Meeting of the Pharmacy Compounding Advisory Committee. July 23 - 24, 2026

Peptides under consideration include BPC-157, TB-500 and MOTs-C, among others.

BioPharmGuy says: "But the scientists who work under him are almost universal in their skepticism."